Long-term follow-up of patients with long-QT syndrome treated with β- blockers and continuous pacing

Circulation

Volumn 100, Issue 24, 1999, Pages 2431-2436

  Dorostkar, Parvin C ^a,b   Eldar, Michael ^a   Belhassen, Bernard ^a   Scheinman, Melvin M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cardioversion; Death, sudden; Defibrillation; Pacemakers; Syncope

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART PACING; HUMAN; LONG QT SYNDROME; LONG TERM CARE; MALE; PRIORITY JOURNAL; SUDDEN DEATH; SYMPATHECTOMY; SYNCOPE;

EID: 0032786115     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.24.2431     Document Type: Article

References (25)

1. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R. The long-QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis. 1988;31:115-172.
2. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall J, Weitkamp L, Vincent M, Garson A, Robinson JL, Benhorin J, Choi S. The long QT syndrome: prospective longitudinal study of 328 families. Circulation. 1991;84:1136-1144.
3. Moss AJ, Liu JE, Gottlieb S, Locati EH, Schwartz PJ, Robinson JL. Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome. Circulation. 1991;84:1524-1529.
4. Vincent GM. Heterogeneity in the inherited long-QT syndrome. J Cardiovasc Electrophysiol. 1995;6:137-146.
5. Priori SG, Napolitano C, Schwartz PJ. Electrophysiologic mechanisms involved in the development of torsades de pointes. Cardiovasc Drug Ther. 1991;5:203-212.
6. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med. 1992;327:846-852.
7. Pacia SV, Devinsky O, Luciano DJ, Vazquez B. The prolonged QT syndrome presenting as epilepsy: a report of two cases and literature review. Neurology. 1994;44:1408-1410.
8. Moss AJ, Robinson J. Clinical features of the idiopathic long-QT syndrome. Circulation. 1992;85(suppl I):I-140-I-144.
9. Eggeling T, Hoeher M, OsterHues HH, Weismueller P, Hombach V. Significance of noninvasive diagnostic techniques in patients with long-QT-syndrome. Am J Cardiol. 1992;70:1421-1416.
10. Keating MT, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M. Linkage of a cardiac arrhythmia, the long-QT syndrome, and the Harvey ras-1 gene. Science. 1991;252:704-706.
11. Jiang C, Atkinson D, Towbin JA, Splawski I, Lehmann MH, Li H, Timothy K, Taggart RT, Schwartz PJ, Vincent GM, Moss AJ, Keating MT. Two long-QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet. 1994;8:141-147.
12. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long-QT syndrome. Cell. 1995;80:795-803.
13. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long-QT syndrome. Cell. 1995;80:805-811.
14. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and acquired cardiac arrhythmia: HERG encodes the Ikr potassium channel. Cell. 1995;81:299-307.
15. Russell MW, Dick M II. The molecular genetics of the congenital long-QT syndromes. Curr Opin Cardiol. 1996;11:45-51.
16. Keating MT. The long-QT syndrome: a review of recent molecular genetic and physiologic discoveries. Medicine. 1996;75:1-5.
17. Keating MT. Genetic approaches to cardiovascular disease: supravalvular aortic stenosis, Williams syndrome, and long-QT syndrome. Circulation. 1995;92:142-147.
18. Towbin JA. Clinical implications of basic research: new revelations about the long-QT syndrome. N Engl J Med. 1995;333:384-385.
19. Schwartz PJ. Idiopathic long-QT syndrome: progress and questions. Am Heart J. 1985;109:399-411.
20. Schwartz PJ, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U. Left cardiac sympathetic denervation in the therapy of congenital long-QT syndrome. Circulation. 1991;84:503-511.
21. Eldar M, Griffin JC, Abbott JA, Benditt D, Bhandari A, Herre JM, Benson DW, Scheinman MM. Permanent cardiac pacing in patients with the long QT syndrome. J Am Coll Cardiol. 1987;10:600-607.
22. Eldar M, Griffin JC, VanHare GF, Witherell C, Bhandari A, Benditt D, Scheinman MM. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long-QT Syndrome. J Am Coll Cardiol. 1992;20:830-837.
23. Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol. 1996;78:703-706.
24. Breithardt G, Wichter T, Haverkamp W, Borggrefe M, Block M, Hammel D, Scheld HH. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome or no structural heart disease. Am Heart J. 1994;127: 1151-1158.
25. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation. 1997;96:2038-2047.